VitruVTRU
Fair Value
US$25
Share price10 Jan
US$9.0763.7% undervalued intrinsic discount
1Y-41.10%
7D4.49%
Distance Learning Scale And Medical Education Will Support A Stronger Long Term Outlook
AN
Analyst High Target compiles bullish analysts opinions to create narratives which represent one standard deviation above the consensus price target, using forecasted revenue and earnings figures, as well as the transcripts of earnings calls
Published
10 Jan 26
Views
2
Not Invested